Standard FDA-approved dosing escalation The FDA-approved tirzepatide dosing schedule, used in the SURMOUNT and SURPASS clinical trials, follows this pattern: Weeks 1 to 4: 2.5 mg once weekly (starting dose) Weeks 5 to 8: 5 mg once weekly Weeks 9 to 12: 7.5 mg once weekly (optional increase) Weeks 13 to 16: 10 mg once weekly (optional increase) Weeks 17 to 20: 12.5 mg once weekly (optional increase) Week 21 and beyond: 15 mg once weekly (maximum dose) Each dose increase happens after a minimum of four weeks at the current dose
Ohno M, Fornerod M, Mattaj IW
This helps us finalize your personalized treatment plan
Find a registered dietitian covered by insurance
Supplementation also becomes necessary because certain conditions, such as exposure to chemotherapy, radiation, heavy metals, etc., require a strong antioxidant to help protect the body and rid it of these oxidative stress markers
Focusing on proven lifestyle strategies, and if necessary, working with a trusted medical provider to explore TRT, can deliver game-changing results